Clinic
Suburban Imaging, LLC
Suburban Imaging, LLC was paid $740K by Medicaid between Jan 2018 and Oct 2024, across 28 billing codes. Its largest line is 74177, Computed tomography, abdomen and pelvis; with contrast material — 50% of everything it billed.
33Billing provider infoSUBURBAN IMAGING, LLC
ROSEVILLE, MN 55113
ROSEVILLE, MN 55113
33aNPI1427008937assigned 05/12/2006
33bProvider typeRadiology Clinic/Center
28Total paid$740K
24GClaims17,177
24DCodes billed28
24AFirst – last monthJan 2018 – Oct 2024
Compared with peers
Next to other Radiology Clinic/Center providers in Minnesota
Rank by total paid#3 of 6
Median peer was paid$96K
This provider vs. median7.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 2,027 | $31K | |
| 2019 | 3,383 | $171K | |
| 2020 | 3,252 | $125K | |
| 2021 | 4,868 | $254K | |
| 2022 | 2,462 | $136K | |
| 2023 | 981 | $21K | |
| 2024incomplete | 204 | $1K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 50% | 2,692 | 2,340 | $371K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 11% | 1,013 | 881 | $84K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 11% | 1,081 | 935 | $81K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 5.2% | 352 | 309 | $39K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 4.9% | 5,506 | 4,573 | $37K |
| A9585 | Injection, gadobutrol, 0.1 ml | 3.1% | 1,636 | 1,027 | $23K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 2.8% | 205 | 174 | $21K |
| 77002 | 2.7% | 402 | 323 | $20K | |
| 73221 | 1.6% | 94 | 79 | $12K | |
| 71250 | 1.6% | 164 | 142 | $12K | |
| Q9965 | Low osmolar contrast material, 100-199 mg/ml iodine concentration, per ml | 1.6% | 2,803 | 1,231 | $12K |
| 72141 | 1.3% | 96 | 90 | $10K |
16 more codes
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 1.2% | 189 | $9K |
| 62323 | <1% | 26 | $4K | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 287 | $2K |
| 20610 | <1% | 44 | $1K | |
| 76536 | <1% | 15 | $1K | |
| 93971 | <1% | 15 | $1K | |
| 76770 | <1% | 16 | $822.90 | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 65 | $296.28 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 15 | $136.79 |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 12 | $75.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 40 | $18.89 |
| G9551 | Final reports for imaging studies without an incidentally found lesion noted | 0% | 46 | $0.00 |
| G9327 | Ct studies performed reported to a radiation dose index registry that is capable of collecting at a minimum all necessary data elements | 0% | 146 | $0.00 |
| G9756 | Surgical procedures that included the use of silicone oil | 0% | 35 | $0.00 |
| G9637 | Final reports with documentation of one or more dose reduction techniques (e.g., automated exposure control, adjustment of the ma and/or kv according to patient size, use of iterative reconstruction technique) | 0% | 165 | $0.00 |
| G9557 | Final reports for ct, cta, mri or mra studies of the chest or neck without an incidentally found thyroid nodule < 1.0 cm noted or no nodule found | 0% | 17 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMADISON, MICHAEL (CEO, PRESIDENT)